COMBINATION THERAPY FOR TYPE II DIABETES OR SYNDROME X

Details for Australian Patent Application No. 2002312400 (hide)

Owner WYETH

Inventors VITOU, Philippe, John, Robert; RANDAZZO, Bruce, Paul; GWYNNE, John, Tomas

Pub. Number AU-A-2002312400

PCT Number PCT/US02/18130

PCT Pub. Number WO2002/098409

Priority 60/296,502 07.06.01 US

Filing date 6 June 2002

Wipo publication date 16 December 2002

International Classifications

A61K 031/343 - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 031/381 - having five-membered rings

A61K 031/404

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 031/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61P 003/10 Drugs for disorders of the metabolism

A61P 003/00 Drugs for disorders of the metabolism

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/296,502 07.06.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002312400

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312401-METHOD AND APPARATUS FOR CANCELING PILOT INTERFERENCE IN A WIRELESS COMMUNICATION SYSTEM

2002312399-INTEGRIN LINKED KINASE MODULATION OF MACROPHAGE ACTIVATION